Genetic risk assessment for women with epithelial ovarian cancer: Referral patterns and outcomes in a university gynecologic oncology clinic

Journal of Genetic Counseling

Volumn 22, Issue 5, 2013, Pages 662-673

  Petzel, Sue V ^a   Vogel, Rachel Isaksson ^b   Bensend, Tracy ^a   Leininger, Anna ^c   Argenta, Peter A ^a   Geller, Melissa A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

BRCA; Genetic counseling; Genetic risk assessment; HPNCC; Ovarian cancer

Indexed keywords

FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; NEOPLASMS, GLANDULAR AND EPITHELIAL; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; OVARIAN NEOPLASMS; PATIENT REFERRAL; RISK ASSESSMENT; UNIVERSITY HOSPITAL; UTILIZATION; ARTICLE; NEOPLASM; OVARY TUMOR; UTILIZATION REVIEW;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOSPITALS, UNIVERSITY; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OUTPATIENT CLINICS, HOSPITAL; OVARIAN NEOPLASMS; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 84885470910     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9598-y     Document Type: Article

References (59)

1. Aktan-Collan, K., Haukkala, A., Pylvanainen, K., Jarvinen, H. J., Aaltonen, L. A., Peltomaki, P., et al. (2007). Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. Journal of Medical Genetics, 44(11), 732-738. doi: 10.1136/jmg.2007.051581.
2. Alsop, K., Fereday, S., Meldrum, C., Defazio, A., Emmanuel, C., George, J., et al. (2012). BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group. Journal of Clinical Oncology, 30(21), 2654-2663. doi: 10.1200/JCO.2011.39.8545.
3. Arden-Jones, A., Kenen, R., & Eeles, R. (2005). Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. European Journal of Cancer Care, 14(3), 272-281.
4. Armstrong, K., Gray, S., & Domchek, S. (2006). Internet use is associated with utilization of genetic counseling for BRCA 1/2 mutations in women with a family history of breast or ovarian cancer. Journal of Clinical Oncology, 24(18S), 10654.
5. Armstrong, K., Micco, E., Carney, A., Stopfer, J., & Putt, M. (2005). Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Journal of the American Medical Association, 293(14), 1729-1736.
6. Balmana, J., Stoffel, E. M., Emmons, K. M., Garber, J. E., & Syngal, S. (2004). Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes. Journal of Medical Genetics, 41(4), e44.
7. Berchuck, A., Heron, K. A., Carney, M. E., Lancaster, J. M., Fraser, E. G., Vinson, V. L., et al. (1998). Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clinical Cancer Research, 4(10), 2433-2437.
8. Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: a systematic review. European Journal of Human Genetics, 8(10), 731-738.
9. Case, D. O., Andrews, J. E., Johnson, J. D., & Allard, S. L. (2005). Avoiding versus seeking: the relationship of information seeking to avoidance, blunting, coping, dissonance, and related concepts. Journal of the Medical Library Association, 93(3), 353-362.
10. Case, D. O., Johnson, J. D., Andrews, J. E., Allard, S. L., & Kelly, K. M. (2004). From two-step flow to the internet: the changing array of sources for genetics information seeking. Journal of the American Society for Information Science and Technology, 55(8), 660-669.
11. Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics. Part A, 116A(1), 11-19. doi: 10.1002/ajmg.a.10868.
12. Culver, J., Burke, W., Yasui, Y., Durfy, S., & Press, N. (2001). Participation in breast cancer genetic counseling: the influence of educational level, ethnic background, and risk perception. Journal of Genetic Counseling, 10(3), 215-231.
13. Daly, M. B., Axilbund, J. E., Bryant, E., Buys, S., Eng, C., Friedman, S., et al. (2006). Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network, 4(2), 156-176.
14. Daniels, M. S., Urbauer, D. L., Stanley, J. L., Johnson, K. G., & Lu, K. H. (2009). Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer. Genetics in Medicine, 11(9), 624-628.
15. Domanska, K., Malander, S., Masback, A., & Nilbert, M. (2007). Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40. International Journal of Gynecological Cancer, 17(4), 789-793.
16. Dutta, M., Pfister, R., & Kosmoski, C. (2010). Consumer evalulation of genetic information online: the role of quality on attitude and behavioral intentions. Journal of Computer-Mediated Communication, 15(4), 592-605.
17. Fackenthal, J. D., & Olopade, O. I. (2007). Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nature Reviews. Cancer, 7(12), 937-948. doi: 10.1038/nrc2054.
18. Forman, A. D., & Hall, M. J. (2009). Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. The Breast Journal, 15(Suppl 1), S56-S62.
19. Freedman, A. N., Wideroff, L., Olson, L., Davis, W., Klabunde, C., Srinath, K. P., et al. (2003). US physicians' attitudes toward genetic testing for cancer susceptibility. American Journal of Medical Genetics. Part A, 120A(1), 63-71. doi: 10.1002/ajmg.a.10192.
20. Gates, M. A., Rosner, B. A., Hecht, J. L., & Tworoger, S. S. (2010). Risk factors for epithelial ovarian cancer by histologic subtype. American Journal of Epidemiology, 171(1), 45-53. doi: 10.1093/aje/kwp314.
21. Gilks, C. B., & Prat, J. (2009). Ovarian carcinoma pathology and genetics: recent advances. Human Pathology, 40(9), 1213-1223.
22. Gritz, E. R., Peterson, S. K., Vernon, S. W., Marani, S. K., Baile, W. F., Watts, B. G., et al. (2005). Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology, 23(9), 1902-1910. doi: 10.1200/JCO.2005.07.102.
23. Hadley, D. W., Jenkins, J., Dimond, E., Nakahara, K., Grogan, L., Liewehr, D. J., et al. (2003). Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Archives of Internal Medicine, 163(5), 573-582.
24. Hughes, C., Fasaye, G. A., LaSalle, V. H., & Finch, C. (2003). Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Education and Counseling, 51(2), 107-114.
25. Keller, M., Jost, R., Kadmon, M., Wullenweber, H. P., Haunstetter, C. M., Willeke, F., et al. (2004). Acceptance of and attitude toward genetic testing for hereditary nonpolyposis colorectal cancer: a comparison of participants and nonparticipants in genetic counseling. Diseases of the Colon & Rectum, 47(2), 153-162.
26. Koehly, L. M., Peterson, S. K., Watts, B. G., Kempf, K. K., Vernon, S. W., & Gritz, E. R. (2003). A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiology, Biomarkers & Prevention, 12(4), 304-313.
27. Kwon, J. S., Daniels, M. S., Sun, C. C., & Lu, K. H. (2010). Preventing future cancers by testing women with ovarian cancer for BRCA mutations. Journal of Clinical Oncology, 28(4), 675-682.
28. Lacour, R. A., Daniels, M. S., Westin, S. N., Meyer, L. A., Burke, C. C., Burns, K. A., et al. (2008). What women with ovarian cancer think and know about genetic testing. Gynecologic Oncology, 111(1), 132-136. doi: 10.1016/j.ygyno.2008.06.016.
29. Lakhani, S. R., Manek, S., Penault-Llorca, F., Flanagan, A., Arnout, L., Merrett, S., et al. (2004). Pathology of ovarian cancers in BRCA1 and BRCA2 carriers. Clinical Cancer Research, 10(7), 2473-2481.
30. Lancaster, J. M., Powell, C. B., Kauff, N. D., Cass, I., Chen, L. M., Lu, K. H., et al. (2007). Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecologic Oncology, 107(2), 159-162.
31. Lapointe, J., Bouchard, K., Patenaude, A. F., Maunsell, E., Simard, J., & Dorval, M. (2012). Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study. Genetics in Medicine, 14(1), 60-68. doi: 10.1038/gim.0b013e3182310a7f.
32. Lerman, C., Hughes, C., Trock, B. J., Myers, R. E., Main, D., Bonney, A., et al. (1999). Genetic testing in families with hereditary nonpolyposis colon cancer. Journal of the American Medical Association, 281(17), 1618-1622.
33. Malander, S., Rambech, E., Kristoffersson, U., Halvarsson, B., Ridderheim, M., Borg, A., et al. (2006). The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer. Gynecologic Oncology, 101(2), 238-243.
34. Markman, M., Markman, M. R., Belland, A., & Petersen, J. (2006). Profile of ovarian cancer patients seeking information from a web-based decision support program. Journal of Women's Health (2002), 15(3), 312-318. doi: 10.1089/jwh.2006.15.312.
35. Meiser, B., Tucker, K., Friedlander, M., Barlow-Stewart, K., Lobb, E., Saunders, C., et al. (2008). Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Research, 10(6), 216.
36. Mellon, S., Berry-Bobovski, L., Gold, R., Levin, N., & Tainsky, M. A. (2006). Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups. Psycho-Oncology, 15(3), 193-208. doi: 10.1002/pon.935.
37. Metcalfe, K. A., Fan, I., McLaughlin, J., Risch, H. A., Rosen, B., Murphy, J., et al. (2009). Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. Gynecologic Oncology, 112(1), 68-72. doi: 10.1016/j.ygyno.2008.10.007.
38. Meyer, L. A., Anderson, M. E., Lacour, R. A., Suri, A., Daniels, M. S., Urbauer, D. L., et al. (2010). Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstetrics and Gynecology, 115(5), 945-952.
39. NCCN Guidelines Panel. (2006). Genetic/Familial high-risk assessment: breast and ovarian. Retrieved from http://www.nccn.org/professionals/physician- gls/pdf/genetics-screening.pdf
40. O'Neill, S. C., White, D. B., Sanderson, S. C., Lipkus, I. M., Bepler, G., Bastian, L. A., et al. (2008). The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes. Genetics in Medicine, 10(2), 121-130. doi: 10.1097/GIM. 0b013e31815f8e06.
41. Pal, T., Permuth-Wey, J., Betts, J. A., Krischer, J. P., Fiorica, J., Arango, H., et al. (2005). BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer, 104(12), 2807-2816.
42. Prat, J., Ribe, A., & Gallardo, A. (2005). Hereditary ovarian cancer. Human Pathology, 36(8), 861-870.
43. Risch, H. A., McLaughlin, J. R., Cole, D. E., Rosen, B., Bradley, L., Kwan, E., et al. (2001). Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. American Journal of Human Genetics, 68(3), 700-710. doi: 10.1086/318787.
44. Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010). American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. Journal of Clinical Oncology, 28(5), 893-901. doi: 10.1200/JCO.2009.27.0660.
45. Ropka, M. E., Wenzel, J., Phillips, E. K., Siadaty, M., & Philbrick, J. T. (2006). Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiology, Biomarkers & Prevention, 15(5), 840-855. doi: 10.1158/1055-9965.EPI-05-0002.
46. Schlich-Bakker, K. J., ten Kroode, H. F., Warlam-Rodenhuis, C. C., van den Bout, J., & Ausems, M. G. (2007). Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer. Genetics in Medicine, 9(11), 766-777. doi: 10.1097/GIM.0b013e318159a318.
47. Schmeler, K. M., Lynch, H. T., Chen, L. M., Munsell, M. F., Soliman, P. T., Clark, M. B., et al. (2006). Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. The New England Journal of Medicine, 354(3), 261-269.
48. Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Isaacs, C., DeMarco, T., et al. (2005). Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention, 14(4), 1003-1007. doi: 10.1158/1055-9965.EPI-03-0545.
49. Siegel, R., Naishadham, D., & Jemal, A. (2013). Cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 63(1), 11-30. doi: 10.3322/caac.21166.
50. Skinner, C. S., Schildkraut, J. M., Berry, D., Calingaert, B., Marcom, P. K., Sugarman, J., et al. (2002). Pre-counseling education materials for BRCA testing: does tailoring make a difference? Genetic Testing, 6(2), 93-105. doi: 10.1089/10906570260199348.
51. Strecher, V. (2007). Internet methods for delivering behavioral and health-related interventions (eHealth). Annual Review of Clinical Psychology, 3, 53-76. doi: 10.1146/annurev.clinpsy.3.022806.091428.
52. The Breast Cancer Linkage Consortium. (1999). Cancer risks in BRCA2 mutation carriers. Journal of the National Cancer Institute, 91(15), 1310-1316.
53. Thomson, M. D., & Hoffman-Goetz, L. (2007). Readability and cultural sensitivity of web-based patient decision aids for cancer screening and treatment: a systematic review. Medical Informatics and the Internet in Medicine, 32(4), 263-286. doi: 10.1080/14639230701780408.
54. Trainer, A. H., Meiser, B., Watts, K., Mitchell, G., Tucker, K., & Friedlander, M. (2010). Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer. Int J Gynecol Cancer, 20(5), 704-716.
55. U.S. Cancer Statistics Working Group. (2012). United States cancer statistics: 1999-2008 Incidence and mortality web-based report. Atlanta, GA: Retrieved from http://www.cdc.gov/uscs
56. Viswanath, K., Breen, N., Meissner, H., Moser, R. P., Hesse, B., Steele, W. R., et al. (2006). Cancer knowledge and disparities in the information age. Journal of Health Communication, 11(Suppl 1), 1-17. doi: 10.1080/ 10810730600977517.
57. Watson, P., Butzow, R., Lynch, H. T., Mecklin, J. P., Jarvinen, H. J., Vasen, H. F., et al. (2001). The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecologic Oncology, 82(2), 223-228.
58. Wideroff, L., Vadaparampil, S. T., Greene, M. H., Taplin, S., Olson, L., & Freedman, A. N. (2005). Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. Journal of Medical Genetics, 42(10), 749-755. doi: 10.1136/jmg.2004.030296.
59. Zhang, S., Royer, R., Li, S., McLaughlin, J. R., Rosen, B., Risch, H. A., et al. (2011). Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecologic Oncology, 121(2), 353-357. doi: 10.1016/j.ygyno.2011.01.020.